Onychomycosis caused by Scopulariopsis brevicaulis with reduced susceptibility to azoles: A rare case report

Nguyen Minh Quang, Le Duc Minh, Nguyen The Vy, Pham Bich Ngoc, Nguyen Thi Thu Thuy, Tran Cam Van

Main Article Content

Abstract

Scopulariopsis brevicaulis is a non-dermatophyte mould that can cause onychomycosis and is often difficult to be diagnosed and treated. We report a case of onychomycosis caused by S. brevicaulis affecting the right great big toenail of a 25-year-old female patient who presented to Hanoi Dermatology Hospital. S. brevicaulis was isolated from the affected nail specimen, producing characteristic brown, powdery colonies when cultured on Sabouraud dextrose agar, and species identification was confirmed by sequencing of the internal transcribed spacer (ITS) region. Microscopic examination under light microscopy revealed branched hyphae with chains of thick-walled, spherical conidia. In vitro antifungal susceptibility testing showed that the isolate exhibited high minimum inhibitory concentrations (MICs) to several azole antifungals. This case underscores the pathogenic potential and decreased susceptibility to azole antifungals of S. brevicaulis in onychomycosis, highlighting the importance of an integrated diagnostic approach - combining direct microscopy, culture, and molecular identification - to ensure accurate diagnosis and guide appropriate therapeutic management.

Article Details

References

1. Pérez-Cantero A, Guarro J. Current knowledge on the etiology and epidemiology of Scopulariopsis infections. Med Mycol. Feb 1 2020;58(2):145-155. doi:10.1093/mmy/myz036
2. Gupta AK, Wang T, Cooper EA, et al. A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management. Journal of the European Academy of Dermatology and Venereology. 2024;38(3):480-495.
3. Gupta AK, Summerbell RC, Venkataraman M, et al. Nondermatophyte mould onychomycosis. J Eur Acad Dermatol Venereol. Aug 2021;35(8):1628-1641. doi:10.1111/jdv.17240
4. Cuenca-Estrella M, Gomez-Lopez A, Buitrago MJ, et al. In vitro activities of 10 combinations of antifungal agents against the multiresistant pathogen Scopulariopsis brevicaulis. Antimicrobial agents and chemotherapy. 2006;50(6):2248-2250.
5. Paredes K, Capilla J, Mayayo E, et al. Virulence and Resistance to Antifungal Therapies of Scopulariopsis Species. Antimicrob Agents Chemother. Apr 2016;60(4):2063-8. doi:10.1128/aac.02275-15
6. Sadeq NM. Fungal Nail Infection. Central Asian Journal of Medical and Natural Science. 2025;6(2):725-730.
7. Walsh TJ, Hayden RT, Larone DH. Larone’s medically important fungi: A guide to identification. John Wiley & Sons; 2018.
8. Kim Y-J, Lim S-W, Suh M-K, et al. Four cases of toenail onychomycosis caused by Scopulariopsis brevicaulis. Korean Journal of Medical Mycology. 2001:97-103.
9. Lee MH, Hwang SM, Suh MK, et al. Onychomycosis caused by Scopulariopsis brevicaulis: report of two cases. Ann Dermatol. May 2012;24(2):209-13. doi:10.5021/ad.2012.24.2.209
10. Gupta AK, Elewski B, Joseph WS, et al. Treatment of onychomycosis in an era of antifungal resistance: role for antifungal stewardship and topical antifungal agents. Mycoses. 2024;67(1):e13683.
11. Axler E, Lipner SR. Antifungal Selection for the Treatment of Onychomycosis: Patient Considerations and Outcomes. Infect Drug Resist. 2024;17:819-843. doi:10.2147/idr.S431526
12. Shemer A, Eshel Y, Gupta AK, et al. Once Weekly Application of Urea 40% and Bifonazole 1% Leads to Earlier Nail Removal in Onychomycosis. Skin Appendage Disord. Sep 2020;6(5):304-308. doi:10.1159/000508926